IL-23-dependent and -independent enhancement pathways of IL-17A production by lactic acid

International Immunology

Volumn 23, Issue 1, 2011, Pages 29-41

  Yabu, Masahiko ^a,b   Shime, Hiroaki ^a,c   Hara, Hiromitsu ^d   Saito, Takashi ^e   Matsumoto, Misako ^c   Seya, Tsukasa ^c   Akazawa, Takashi ^a   Inoue, Norimitsu ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d SAGA UNIVERSITY   (Japan)

^e Institute of Physical and Chemical Research   (Japan)

Author keywords

IL 17; IL 23; Inflammation; Lactic acid; Tumor

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 9; CD40 ANTIGEN; CD40 LIGAND; HOMODIMER; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 23P40; LACTIC ACID; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MEDIATOR; MEMORY T LYMPHOCYTE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; UPREGULATION;

EID: 78650359602     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxq455     Document Type: Article

References (51)

1. Karin, M., Lawrence, T. and Nizet, V. 2006. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124:823.
2. Petrilli, V., Dostert, C., Muruve, D. A. and Tschopp, J. 2007. The inflammasome: a danger sensing complex triggering innate immunity. Curr. Opin. Immunol. 19:615.
3. Apetoh, L., Ghiringhelli, F., Tesniere, A. et al. 2007. The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol. Rev. 220:47.
4. Bianchi, M. E. and Manfredi, A. A. 2007. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol. Rev. 220:35.
5. Duncan, J. A., Bergstralh, D. T., Wang, Y. et al. 2007. Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling. Proc. Natl Acad. Sci. USA 104:8041.
6. Mariathasan, S., Weiss, D. S., Newton, K. et al. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:228.
7. Sutterwala, F. S., Ogura, Y., Szczepanik, M. et al. 2006. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24:317.
8. Yamasaki, S., Ishikawa, E., Sakuma, M., Hara, H., Ogata, K. and Saito, T. 2008. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat. Immunol. 9:1179.
9. Kolls, J. K. and Linden, A. 2004. Interleukin-17 family members and inflammation. Immunity 21:467.
10. Park, H., Li, Z., Yang, X. O. et al. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:1133.
11. Harrington, L. E., Hatton, R. D., Mangan, P. R. et al. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123.
12. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. and Stockinger, B. 2006. TGF® in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179.
13. Bettelli, E., Korn, T., Oukka, M. and Kuchroo, V. K. 2008. Induction and effector functions of TH17 cells. Nature 453:1051.
14. McGeachy, M. J., Chen, Y., Tato, C. M. et al. 2009. The interleukin receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat. Immunol. 10:314.
15. Stritesky, G. L., Yeh, N. and Kaplan, M. H. 2008. IL-23 promotes maintenance but not commitment to the Th17 lineage. J. Immunol. 181:5948.
16. Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J. and Gurney, A. L. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278:1910.
17. Korn, T., Bettelli, E., Oukka, M. and Kuchroo, V. K. 2009. IL-17 and Th17 cells. Annu. Rev. Immunol. 27:485.
18. Abraham, C. and Cho, J. H. 2009. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 60:97.
19. Langowski, J. L., Zhang, X., Wu, L. et al. 2006. IL-23 promotes tumour incidence and growth. Nature 442:461.
20. Kortylewski, M., Xin, H., Kujawski, M. et al. 2009. Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell 15:114.
21. Shime, H., Yabu, M., Akazawa, T. et al. 2008. Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway. J. Immunol. 180:7175.
22. Kim, J. W. and Dang, C. V. 2006. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res. 66:8927.
23. Walenta, S. and Mueller-Klieser, W. F. 2004. Lactate: mirror and motor of tumor malignancy. Semin. Radiat. Oncol. 14:267.
24. Gottfried, E., Kunz-Schughart, L. A., Ebner, S. et al. 2006. Tumorderived lactic acid modulates dendritic cell activation and antigen expression. Blood 107:2013.
25. Fischer, K., Hoffmann, P., Voelkl, S. et al. 2007. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109:3812.
26. Barnden, M. J., Allison, J., Heath, W. R. and Carbone, F. R. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based α-and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76:34.
27. Kaisho, T., Takeuchi, O., Kawai, T., Hoshino, K. and Akira, S. 2001. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J. Immunol. 166:5688.
28. Hara, H., Ishihara, C., Takeuchi, A. et al. 2007. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat. Immunol. 8:619.
29. Suzuki, K., Okuno, T., Yamamoto, M. et al. 2007. Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1-beta1 integrin. Nature 446:680.
30. Akazawa, T., Shingai, M., Sasai, M. et al. 2007. Tumor immunotherapy using bone marrow-derived dendritic cells overexpressing Toll-like receptor adaptors. FEBS Lett. 581:3334.
31. Livak, K. J. and Schmittgen, T. D. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402.
32. Halestrap, A. P. and Price, N. T. 1999. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J (343 Pt) 2:281.
33. Speirs, K., Caamano, J., Goldschmidt, M. H., Hunter, C. A. and Scott, P. 2002. NF-kappa B2 is required for optimal CD40-induced IL-12 production but dispensable for Th1 cell differentiation. J. Immunol. 168:4406.
34. Kato, T., Hakamada, R., Yamane, H. and Nariuchi, H. 1996. Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction. J. Immunol. 156:3932.
35. Schulz, O., Edwards, A. D., Schito, M., Aliberti, J., Manickasingham, S., Sher, A. and Reis e Sousa, C. 2000. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 13:453.
36. Kiener, P. A., Moran-Davis, P., Rankin, B. M., Wahl, A. F., Aruffo, A. and Hollenbaugh, D. 1995. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J. Immunol. 155:4917.
37. Coope, H. J., Atkinson, P. G., Huhse, B. et al. 2002. CD40 regulates the processing of NF-kappaB2 p100 to p52. EMBO J. 21:5375.
38. Sutton, C., Brereton, C., Keogh, B., Mills, K. H. and Lavelle, E. C. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203:1685.
39. Cho, M. L., Kang, J. W., Moon, Y. M. et al. 2006. STAT3 and NFkappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J. Immunol. 176:5652.
40. Chung, Y., Chang, S. H., Martinez, G. J. et al. 2009. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30:576.
41. Balkwill, F., Charles, K. A. and Mantovani, A. 2005. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7:211.
42. de Visser, K. E., Eichten, A. and Coussens, L. M. 2006. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer 6:24.
43. Samuvel, D. J., Sundararaj, K. P., Nareika, A., Lopes-Virella, M. F. and Huang, Y. 2009. Lactate boosts TLR4 signaling and NFkappaB pathway-mediated gene transcription in macrophages via monocarboxylate transporters and MD-2 up-regulation. J. Immunol. 182:2476.
44. LeibundGut-Landmann, S., Gross, O., Robinson, M. J. et al. 2007. Syk-and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8:630.
45. Cai, T. Q., Ren, N., Jin, L. et al. 2008. Role of GPR81 in lactatemediated reduction of adipose lipolysis. Biochem. Biophys. Res. Commun. 377:987.
46. Liu, C., Wu, J., Zhu, J. et al. 2009. Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81. J. Biol. Chem. 284:2811.
47. Ahmed, K., Tunaru, S. and Offermanns, S. 2009. GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors. Trends Pharmacol. Sci. 30:557.
48. Dietl, K., Renner, K., Dettmer, K. et al. 2010. Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes. J. Immunol. 184:1200.
49. Gatenby, R. A. and Gillies, R. J. 2004. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4:891.
50. Zou, W. and Restifo, N. P. 2010. T(H)17 cells in tumour immunity and immunotherapy. Nat. Rev. Immunol. 10:248.
51. Fantin, V. R., St-Pierre, J. and Leder, P. 2006. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9:425.